Journal of AIDS & Clinical Research

Rebecca M Schwartz

Publications

• Research Article
  The Presence of a Malignant Comorbidity is a Significant Predictor of Increased 30-Day Hospital Readmission Rates in HIV-1 Infected Individuals
  Author(s): Juan Carlos Rico, Rebecca M Schwartz, Joseph McGowan and Daniel O GriffinJuan Carlos Rico, Rebecca M Schwartz, Joseph McGowan and Daniel O Griffin
  
  Thirty-day hospital readmission is a benchmark for quality of care. HIV-1-infected individuals have a significantly increased 30-day readmission rate compared to their HIV-1-uninfected peers. Prior work has identified an association between several factors with an increased 30-day readmission rate in HIV-1-infected individuals. With malignancy recognized as a growing problem for HIV-1-infected patients, we sought to determine, in a cohort of 775 hospitalized patients with access to outpatient care, whether the presence of malignancy was a predictor of 30-day readmission. Of these 775 patients, 440 patients met the inclusion criteria for this study. We observed that the presence of a malignant comorbidity was a significant predictor of increased hospital 30-day readmission rates in HIV-1-infected individuals. The odds ratio for 30-day readmission with a co-morbid diagn.. Read More»
  DOI: 10.4172/2155-6113.1000532

  Abstract PDF